Medication/en - Revision history

FuzzyBot: Updating to match new version of source page

2023-11-05T08:09:41Z

Updating to match new version of source page

← Older revision		Revision as of 17:09, 5 November 2023
Line 1:		Line 1:
			{{Drug List/ja}}
	<languages/>		<languages/>
	{{short description\|Substance used to diagnose, cure, treat, or prevent disease}}		{{short description\|Substance used to diagnose, cure, treat, or prevent disease}}

FuzzyBot: Updating to match new version of source page

2023-07-23T22:50:47Z

Updating to match new version of source page

← Older revision		Revision as of 07:50, 24 July 2023
Line 376:		Line 376:
	{{Main\|Environmental impact of pharmaceuticals and personal care products}}		{{Main\|Environmental impact of pharmaceuticals and personal care products}}

	The environmental impact of pharmaceuticals and personal care products is controversial. PPCPs are substances used by individuals for personal health or [[cosmetics\|cosmetic]] reasons and the products used by [[agribusiness\|agribusiness]] to boost growth or health of livestock. PPCPs comprise a diverse collection of thousands of chemical substances, including prescription and over-the-counter therapeutic drugs, veterinary drugs, fragrances, and cosmetics. PPCPs have been detected in water bodies throughout the world and ones that persist in the environment are called [[Environmental Persistent Pharmaceutical Pollutant\|Environmental Persistent Pharmaceutical Pollutant]]s. The effects of these chemicals on humans and the environment are not yet known, but to date there is no scientific evidence that they affect human health.		The environmental impact of pharmaceuticals and personal care products is controversial. PPCPs are substances used by individuals for personal health or [[:en:cosmetics\|cosmetic]] reasons and the products used by [[:en:agribusiness\|agribusiness]] to boost growth or health of livestock. PPCPs comprise a diverse collection of thousands of chemical substances, including prescription and over-the-counter therapeutic drugs, veterinary drugs, fragrances, and cosmetics. PPCPs have been detected in water bodies throughout the world and ones that persist in the environment are called [[Environmental Persistent Pharmaceutical Pollutant\|Environmental Persistent Pharmaceutical Pollutant]]s. The effects of these chemicals on humans and the environment are not yet known, but to date there is no scientific evidence that they affect human health.


	== See also ==		== See also ==

FuzzyBot: Updating to match new version of source page

2023-07-22T22:50:15Z

Updating to match new version of source page

← Older revision		Revision as of 07:50, 23 July 2023
Line 366:		Line 366:
	Essential medicines, as defined by the [[World Health Organization\|World Health Organization]] (WHO), are "those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford." Recent studies have found that most of the medicines on the WHO essential medicines list, outside of the field of HIV drugs, are not patented in the developing world, and that lack of widespread [[Access to medicines\|access to these medicines]] arise from issues fundamental to economic development – lack of infrastructure and poverty. [[Médecins Sans Frontières\|Médecins Sans Frontières]] also runs a [[Campaign for Access to Essential Medicines\|Campaign for Access to Essential Medicines]] campaign, which includes advocacy for greater resources to be devoted to currently untreatable diseases that primarily occur in the developing world. The [[Access to Medicine Index\|Access to Medicine Index]] tracks how well pharmaceutical companies make their products available in the developing world.		Essential medicines, as defined by the [[World Health Organization\|World Health Organization]] (WHO), are "those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford." Recent studies have found that most of the medicines on the WHO essential medicines list, outside of the field of HIV drugs, are not patented in the developing world, and that lack of widespread [[Access to medicines\|access to these medicines]] arise from issues fundamental to economic development – lack of infrastructure and poverty. [[Médecins Sans Frontières\|Médecins Sans Frontières]] also runs a [[Campaign for Access to Essential Medicines\|Campaign for Access to Essential Medicines]] campaign, which includes advocacy for greater resources to be devoted to currently untreatable diseases that primarily occur in the developing world. The [[Access to Medicine Index\|Access to Medicine Index]] tracks how well pharmaceutical companies make their products available in the developing world.

	[[World Trade Organization\|World Trade Organization]] negotiations in the 1990s, including the [[TRIPS Agreement\|TRIPS Agreement]] and the [[Doha Declaration\|Doha Declaration]], have centered on issues at the intersection of international trade in pharmaceuticals and [[intellectual property rights\|intellectual property rights]], with developed world nations seeking strong intellectual property rights to protect investments made to develop new drugs, and developing world nations seeking to promote their generic pharmaceuticals industries and their ability to make medicine available to their people via [[compulsory licenses\|compulsory licenses]].		[[:en:World Trade Organization\|World Trade Organization]] negotiations in the 1990s, including the [[:en:TRIPS Agreement\|TRIPS Agreement]] and the [[:en:Doha Declaration\|Doha Declaration]], have centered on issues at the intersection of international trade in pharmaceuticals and [[:en:intellectual property rights\|intellectual property rights]], with developed world nations seeking strong intellectual property rights to protect investments made to develop new drugs, and developing world nations seeking to promote their generic pharmaceuticals industries and their ability to make medicine available to their people via [[:en:compulsory licenses\|compulsory licenses]].

	Some have raised ethical objections specifically with respect to pharmaceutical patents and the high prices for drugs that they enable their proprietors to charge, which poor people around the world, cannot afford. Critics also question the rationale that exclusive patent rights and the resulting high prices are required for pharmaceutical companies to recoup the large investments needed for research and development. One study concluded that marketing expenditures for new drugs often doubled the amount that was allocated for research and development. Other critics claim that patent settlements would be costly for consumers, the health care system, and state and federal governments because it would result in delaying access to lower cost generic medicines.		Some have raised ethical objections specifically with respect to pharmaceutical patents and the high prices for drugs that they enable their proprietors to charge, which poor people around the world, cannot afford. Critics also question the rationale that exclusive patent rights and the resulting high prices are required for pharmaceutical companies to recoup the large investments needed for research and development. One study concluded that marketing expenditures for new drugs often doubled the amount that was allocated for research and development. Other critics claim that patent settlements would be costly for consumers, the health care system, and state and federal governments because it would result in delaying access to lower cost generic medicines.

	[[Novartis\|Novartis]] fought a protracted battle with the government of India over the patenting of its drug, [[Gleevec\|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[Novartis v. Union of India & Others\|Novartis v. Union of India & Others]]. The Supreme Court ruled narrowly against Novartis, but opponents of patenting drugs claimed it as a major victory.		[[Novartis\|Novartis]] fought a protracted battle with the government of India over the patenting of its drug, [[Gleevec\|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[:en:Novartis v. Union of India & Others\|Novartis v. Union of India & Others]]. The Supreme Court ruled narrowly against Novartis, but opponents of patenting drugs claimed it as a major victory.

	===Environmental issues===		===Environmental issues===

FuzzyBot: Updating to match new version of source page

2023-07-16T01:26:08Z

Updating to match new version of source page

← Older revision		Revision as of 10:26, 16 July 2023
Line 326:		Line 326:
	===Modern pharmacology===		===Modern pharmacology===

	For most of the 19th century, drugs were not highly effective, leading [[Oliver Wendell Holmes, Sr.\|Oliver Wendell Holmes, Sr.]] to famously comment in 1842 that "if all medicines in the world were thrown into the sea, it would be all the better for mankind and all the worse for the fishes".		For most of the 19th century, drugs were not highly effective, leading [[:en:Oliver Wendell Holmes, Sr.\|Oliver Wendell Holmes, Sr.]] to famously comment in 1842 that "if all medicines in the world were thrown into the sea, it would be all the better for mankind and all the worse for the fishes".

	During the [[First World War\|First World War]], [[Alexis Carrel\|Alexis Carrel]] and [[Henry Drysdale Dakin\|Henry Dakin]] developed the Carrel-Dakin method of treating wounds with an irrigation, Dakin's solution, a germicide which helped prevent [[gangrene\|gangrene]].		During the [[:en:First World War\|First World War]], [[:en:Alexis Carrel\|Alexis Carrel]] and [[:en:Henry Drysdale Dakin\|Henry Dakin]] developed the Carrel-Dakin method of treating wounds with an irrigation, Dakin's solution, a germicide which helped prevent [[gangrene\|gangrene]].

	In the inter-war period, the first anti-bacterial agents such as the [[sulpha\|sulpha]] antibiotics were developed. The Second World War saw the introduction of widespread and effective antimicrobial therapy with the development and mass production of [[penicillin\|penicillin]] antibiotics, made possible by the pressures of the war and the collaboration of British scientists with the American [[pharmaceutical industry\|pharmaceutical industry]].		In the inter-war period, the first anti-bacterial agents such as the [[sulpha\|sulpha]] antibiotics were developed. The Second World War saw the introduction of widespread and effective antimicrobial therapy with the development and mass production of [[penicillin\|penicillin]] antibiotics, made possible by the pressures of the war and the collaboration of British scientists with the American [[pharmaceutical industry\|pharmaceutical industry]].

FuzzyBot: Updating to match new version of source page

2023-07-13T04:58:45Z

Updating to match new version of source page

← Older revision		Revision as of 13:58, 13 July 2023
Line 320:		Line 320:
	===Medieval pharmacology===		===Medieval pharmacology===

	[[Al-Kindi\|Al-Kindi]]'s ninth century AD book, ''[[De Gradibus\|De Gradibus]]'' and [[Ibn Sina\|Ibn Sina]] (Avicenna)'s ''[[The Canon of Medicine\|The Canon of Medicine]]'', covers a range of drugs known to the practice of [[medicine in the medieval Islamic world\|medicine in the medieval Islamic world]].		[[:en:Al-Kindi\|Al-Kindi]]'s ninth century AD book, ''[[:en:De Gradibus\|De Gradibus]]'' and [[:en:Ibn Sina\|Ibn Sina]] (Avicenna)'s ''[[:en:The Canon of Medicine\|The Canon of Medicine]]'', covers a range of drugs known to the practice of [[medicine in the medieval Islamic world\|medicine in the medieval Islamic world]].

	[[Medieval medicine of Western Europe\|Medieval medicine of Western Europe]] saw advances in surgery compared to previously, but few truly effective drugs existed, beyond [[opium\|opium]] (found in such extremely popular drugs as the "Great Rest" of the [[Antidotarium Nicolai\|Antidotarium Nicolai]] at the time) and [[quinine\|quinine]]. Folklore cures and potentially poisonous metal-based compounds were popular treatments. [[Theodoric Borgognoni\|Theodoric Borgognoni]], (1205–1296), one of the most significant surgeons of the medieval period, responsible for introducing and promoting important surgical advances including basic [[antiseptic\|antiseptic]] practice and the use of [[anaesthetic\|anaesthetic]]s. [[Garcia de Orta\|Garcia de Orta]] described some herbal treatments that were used.		[[Medieval medicine of Western Europe\|Medieval medicine of Western Europe]] saw advances in surgery compared to previously, but few truly effective drugs existed, beyond [[opium\|opium]] (found in such extremely popular drugs as the "Great Rest" of the [[:en:Antidotarium Nicolai\|Antidotarium Nicolai]] at the time) and [[quinine\|quinine]]. Folklore cures and potentially poisonous metal-based compounds were popular treatments. [[:en:Theodoric Borgognoni\|Theodoric Borgognoni]], (1205–1296), one of the most significant surgeons of the medieval period, responsible for introducing and promoting important surgical advances including basic [[antiseptic\|antiseptic]] practice and the use of [[anaesthetic\|anaesthetic]]s. [[:en:Garcia de Orta\|Garcia de Orta]] described some herbal treatments that were used.

	===Modern pharmacology===		===Modern pharmacology===

FuzzyBot: Updating to match new version of source page

2023-07-12T02:19:55Z

Updating to match new version of source page

← Older revision		Revision as of 11:19, 12 July 2023
Line 310:		Line 310:
	Using plants and plant substances to treat all kinds of diseases and medical conditions is believed to date back to [[prehistoric medicine\|prehistoric medicine]].		Using plants and plant substances to treat all kinds of diseases and medical conditions is believed to date back to [[prehistoric medicine\|prehistoric medicine]].

	The [[Kahun Gynaecological Papyrus\|Kahun Gynaecological Papyrus]], the oldest known medical text of any kind, dates to about 1800 BC and represents the first documented use of any kind of drug. It and other [[medical papyri\|medical papyri]] describe [[Ancient Egyptian medicine\|Ancient Egyptian medical practices]], such as using [[honey\|honey]] to treat infections and the legs of bee-eaters to treat neck pains.		The [[:en:Kahun Gynaecological Papyrus\|Kahun Gynaecological Papyrus]], the oldest known medical text of any kind, dates to about 1800 BC and represents the first documented use of any kind of drug. It and other [[medical papyri\|medical papyri]] describe [[Ancient Egyptian medicine\|Ancient Egyptian medical practices]], such as using [[honey\|honey]] to treat infections and the legs of bee-eaters to treat neck pains.

	Ancient [[Babylonian medicine\|Babylonian medicine]] demonstrated the use of medication in the first half of the [[2nd millennium BC\|2nd millennium BC]]. [[Cream (pharmaceutical)\|Medicinal creams]] and [[Pill (pharmacy)\|pills]] were employed as treatments.		Ancient [[Babylonian medicine\|Babylonian medicine]] demonstrated the use of medication in the first half of the [[:en:2nd millennium BC\|2nd millennium BC]]. [[Cream (pharmaceutical)\|Medicinal creams]] and [[Pill (pharmacy)\|pills]] were employed as treatments.

	On the Indian subcontinent, the [[Atharvaveda\|Atharvaveda]], a sacred text of [[Hinduism\|Hinduism]] whose core dates from the second millennium BC, although the hymns recorded in it are believed to be older, is the first Indic text dealing with medicine. It describes plant-based drugs to counter diseases. The earliest foundations of [[ayurveda\|ayurveda]] were built on a synthesis of selected ancient herbal practices, together with a massive addition of theoretical conceptualizations, new [[nosology\|nosologies]] and new therapies dating from about 400 BC onwards. The student of Āyurveda was expected to know ten arts that were indispensable in the preparation and application of his medicines: distillation, operative skills, cooking, horticulture, metallurgy, sugar manufacture, pharmacy, analysis and separation of minerals, compounding of metals, and preparation of [[alkalis\|alkalis]].		On the Indian subcontinent, the [[:en:Atharvaveda\|Atharvaveda]], a sacred text of [[:en:Hinduism\|Hinduism]] whose core dates from the second millennium BC, although the hymns recorded in it are believed to be older, is the first Indic text dealing with medicine. It describes plant-based drugs to counter diseases. The earliest foundations of [[ayurveda\|ayurveda]] were built on a synthesis of selected ancient herbal practices, together with a massive addition of theoretical conceptualizations, new [[:en:nosology\|nosologies]] and new therapies dating from about 400 BC onwards. The student of Āyurveda was expected to know ten arts that were indispensable in the preparation and application of his medicines: distillation, operative skills, cooking, horticulture, metallurgy, sugar manufacture, pharmacy, analysis and separation of minerals, compounding of metals, and preparation of [[:en:alkalis\|alkalis]].

	The [[Hippocratic Oath\|Hippocratic Oath]] for physicians, attributed to fifth century BC Greece, refers to the existence of "deadly drugs", and [[Medicine in ancient Greece\|ancient Greek physicians]] imported drugs from Egypt and elsewhere. The [[pharmacopoeia\|pharmacopoeia]] ''[[De materia medica\|De materia medica]],'' written between 50 and 70 CE by the Greek physician [[Pedanius Dioscorides\|Pedanius Dioscorides]], was widely read for more than 1,500 years.		The [[Hippocratic Oath\|Hippocratic Oath]] for physicians, attributed to fifth century BC Greece, refers to the existence of "deadly drugs", and [[Medicine in ancient Greece\|ancient Greek physicians]] imported drugs from Egypt and elsewhere. The [[pharmacopoeia\|pharmacopoeia]] ''[[:en:De materia medica\|De materia medica]],'' written between 50 and 70 CE by the Greek physician [[:en:Pedanius Dioscorides\|Pedanius Dioscorides]], was widely read for more than 1,500 years.

	===Medieval pharmacology===		===Medieval pharmacology===

FuzzyBot: Updating to match new version of source page

2023-07-07T02:37:44Z

Updating to match new version of source page

← Older revision		Revision as of 11:37, 7 July 2023
Line 256:		Line 256:
	===United Kingdom===		===United Kingdom===

	In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[National Health Service\|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[Association of the British Pharmaceutical Industry\|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.		In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[:en:National Health Service\|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[:en:Association of the British Pharmaceutical Industry\|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.

	===Canada===		===Canada===
Line 268:		Line 268:
	=== India ===		=== India ===

	In India, drug prices are regulated by the [[National Pharmaceutical Pricing Authority\|National Pharmaceutical Pricing Authority]].		In India, drug prices are regulated by the [[:en:National Pharmaceutical Pricing Authority\|National Pharmaceutical Pricing Authority]].

	===United States===		===United States===

FuzzyBot: Updating to match new version of source page

2023-07-06T22:35:49Z

Updating to match new version of source page

← Older revision		Revision as of 07:35, 7 July 2023
Line 244:		Line 244:
	Depending upon the [[jurisdiction\|jurisdiction]], drugs may be divided into [[over-the-counter drug\|over-the-counter drug]]s (OTC) which may be available without special restrictions, and [[prescription drug\|prescription drug]]s, which must be [[Medical prescription\|prescribed]] by a licensed medical practitioner in accordance with [[medical guideline\|medical guideline]]s due to the risk of adverse effects and [[contraindication\|contraindication]]s. The precise distinction between OTC and prescription depends on the legal jurisdiction. A third category, "behind-the-counter" drugs, is implemented in some jurisdictions. These do not require a prescription, but must be kept in the [[dispensary\|dispensary]], not visible to the public, and be sold only by a [[pharmacist\|pharmacist]] or [[pharmacy technician\|pharmacy technician]]. Doctors may also prescribe prescription drugs for [[off-label use\|off-label use]] – purposes which the drugs were not originally approved for by the regulatory agency. The [[Classification of Pharmaco-Therapeutic Referrals\|Classification of Pharmaco-Therapeutic Referrals]] helps guide the referral process between pharmacists and doctors.		Depending upon the [[jurisdiction\|jurisdiction]], drugs may be divided into [[over-the-counter drug\|over-the-counter drug]]s (OTC) which may be available without special restrictions, and [[prescription drug\|prescription drug]]s, which must be [[Medical prescription\|prescribed]] by a licensed medical practitioner in accordance with [[medical guideline\|medical guideline]]s due to the risk of adverse effects and [[contraindication\|contraindication]]s. The precise distinction between OTC and prescription depends on the legal jurisdiction. A third category, "behind-the-counter" drugs, is implemented in some jurisdictions. These do not require a prescription, but must be kept in the [[dispensary\|dispensary]], not visible to the public, and be sold only by a [[pharmacist\|pharmacist]] or [[pharmacy technician\|pharmacy technician]]. Doctors may also prescribe prescription drugs for [[off-label use\|off-label use]] – purposes which the drugs were not originally approved for by the regulatory agency. The [[Classification of Pharmaco-Therapeutic Referrals\|Classification of Pharmaco-Therapeutic Referrals]] helps guide the referral process between pharmacists and doctors.

	The [[International Narcotics Control Board\|International Narcotics Control Board]] of the [[United Nations\|United Nations]] imposes a world law of [[prohibition\|prohibition]] of certain drugs. They publish a lengthy list of chemicals and plants whose trade and consumption (where applicable) is forbidden. OTC drugs are sold without restriction as they are considered safe enough that most people will not hurt themselves accidentally by taking it as instructed. Many countries, such as the United Kingdom have a third category of "pharmacy medicines", which can be sold only in registered [[pharmacy\|pharmacies]] by or under the supervision of a pharmacist.		The [[:en:International Narcotics Control Board\|International Narcotics Control Board]] of the [[:en:United Nations\|United Nations]] imposes a world law of [[:en:prohibition\|prohibition]] of certain drugs. They publish a lengthy list of chemicals and plants whose trade and consumption (where applicable) is forbidden. OTC drugs are sold without restriction as they are considered safe enough that most people will not hurt themselves accidentally by taking it as instructed. Many countries, such as the United Kingdom have a third category of "pharmacy medicines", which can be sold only in registered [[pharmacy\|pharmacies]] by or under the supervision of a pharmacist.

	[[Medical error\|Medical error]]s include over prescription and [[polypharmacy\|polypharmacy]], mis-prescription, contraindication and lack of detail in dosage and administrations instructions. In 2000 the definition of a prescription error was studied using a [[Delphi method\|Delphi method]] conference; the conference was motivated by ambiguity in the what a prescription error and a need to use a uniform definition in studies.		[[Medical error\|Medical error]]s include over prescription and [[polypharmacy\|polypharmacy]], mis-prescription, contraindication and lack of detail in dosage and administrations instructions. In 2000 the definition of a prescription error was studied using a [[:en:Delphi method\|Delphi method]] conference; the conference was motivated by ambiguity in the what a prescription error and a need to use a uniform definition in studies.

	==Drug pricing==		==Drug pricing==

FuzzyBot: Updating to match new version of source page

2023-07-03T08:23:24Z

Updating to match new version of source page

← Older revision		Revision as of 17:23, 3 July 2023
Line 201:		Line 201:
	[[Oral administration\|Oral administration]], the most common form of enteral administration, can be performed using various [[dosage forms\|dosage forms]] including [[Tablet (pharmacy)\|tablets]] or [[capsule (pharmacy)\|capsules]] and liquid such as a syrup or suspension. Other ways to take medication include [[buccal administration\|buccally]] (placed inside cheek), [[Sublingual administration\|sublingually]] (placed underneath tongue), [[eye\|eye]] and [[ear drop\|ear drop]]s (dropped into eye or ear), and transdermally (applied to skin).		[[Oral administration\|Oral administration]], the most common form of enteral administration, can be performed using various [[dosage forms\|dosage forms]] including [[Tablet (pharmacy)\|tablets]] or [[capsule (pharmacy)\|capsules]] and liquid such as a syrup or suspension. Other ways to take medication include [[buccal administration\|buccally]] (placed inside cheek), [[Sublingual administration\|sublingually]] (placed underneath tongue), [[eye\|eye]] and [[ear drop\|ear drop]]s (dropped into eye or ear), and transdermally (applied to skin).

	They can be administered in one dose, as a [[bolus (medicine)\|bolus]]. Administration frequencies are often abbreviated from Latin, such as ''every 8 hours'' reading Q8H from ''Quaque VIII Hora''. The drug frequencies are often expressed as the number of times a drug is used per day (e.g., four times a day). It~~{{specify\|date=November 2022}}~~ may include event-related information (e.g., 1 hour before meals, in the morning, at bedtime), or complimentary to interval, although equivalent expressions may have different implications (e.g., every 8 hours versus 3 times a day).		They can be administered in one dose, as a [[bolus (medicine)\|bolus]]. Administration frequencies are often abbreviated from Latin, such as ''every 8 hours'' reading Q8H from ''Quaque VIII Hora''. The drug frequencies are often expressed as the number of times a drug is used per day (e.g., four times a day). It may include event-related information (e.g., 1 hour before meals, in the morning, at bedtime), or complimentary to interval, although equivalent expressions may have different implications (e.g., every 8 hours versus 3 times a day).

	==Drug discovery==		==Drug discovery==

FuzzyBot: Updating to match new version of source page

2023-07-03T06:30:02Z

Updating to match new version of source page

← Older revision		Revision as of 15:30, 3 July 2023
Line 405:		Line 405:
	{{Major Drug Groups}}		{{Major Drug Groups}}
	{{Pharmacy}}		{{Pharmacy}}
			{{二次利用}}

	[[Category:Drugs\| ]]		[[Category:Drugs\| ]]

← Older revision		Revision as of 11:19, 12 July 2023
Line 310:		Line 310:
	Using plants and plant substances to treat all kinds of diseases and medical conditions is believed to date back to [[prehistoric medicine\|prehistoric medicine]].		Using plants and plant substances to treat all kinds of diseases and medical conditions is believed to date back to [[prehistoric medicine\|prehistoric medicine]].

	The [[Kahun Gynaecological Papyrus\|Kahun Gynaecological Papyrus]], the oldest known medical text of any kind, dates to about 1800 BC and represents the first documented use of any kind of drug. It and other [[medical papyri\|medical papyri]] describe [[Ancient Egyptian medicine\|Ancient Egyptian medical practices]], such as using [[honey\|honey]] to treat infections and the legs of bee-eaters to treat neck pains.		The [[:en:Kahun Gynaecological Papyrus\|Kahun Gynaecological Papyrus]], the oldest known medical text of any kind, dates to about 1800 BC and represents the first documented use of any kind of drug. It and other [[medical papyri\|medical papyri]] describe [[Ancient Egyptian medicine\|Ancient Egyptian medical practices]], such as using [[honey\|honey]] to treat infections and the legs of bee-eaters to treat neck pains.

	Ancient [[Babylonian medicine\|Babylonian medicine]] demonstrated the use of medication in the first half of the [[2nd millennium BC\|2nd millennium BC]]. [[Cream (pharmaceutical)\|Medicinal creams]] and [[Pill (pharmacy)\|pills]] were employed as treatments.		Ancient [[Babylonian medicine\|Babylonian medicine]] demonstrated the use of medication in the first half of the [[:en:2nd millennium BC\|2nd millennium BC]]. [[Cream (pharmaceutical)\|Medicinal creams]] and [[Pill (pharmacy)\|pills]] were employed as treatments.

	On the Indian subcontinent, the [[Atharvaveda\|Atharvaveda]], a sacred text of [[Hinduism\|Hinduism]] whose core dates from the second millennium BC, although the hymns recorded in it are believed to be older, is the first Indic text dealing with medicine. It describes plant-based drugs to counter diseases. The earliest foundations of [[ayurveda\|ayurveda]] were built on a synthesis of selected ancient herbal practices, together with a massive addition of theoretical conceptualizations, new [[nosology\|nosologies]] and new therapies dating from about 400 BC onwards. The student of Āyurveda was expected to know ten arts that were indispensable in the preparation and application of his medicines: distillation, operative skills, cooking, horticulture, metallurgy, sugar manufacture, pharmacy, analysis and separation of minerals, compounding of metals, and preparation of [[alkalis\|alkalis]].		On the Indian subcontinent, the [[:en:Atharvaveda\|Atharvaveda]], a sacred text of [[:en:Hinduism\|Hinduism]] whose core dates from the second millennium BC, although the hymns recorded in it are believed to be older, is the first Indic text dealing with medicine. It describes plant-based drugs to counter diseases. The earliest foundations of [[ayurveda\|ayurveda]] were built on a synthesis of selected ancient herbal practices, together with a massive addition of theoretical conceptualizations, new [[:en:nosology\|nosologies]] and new therapies dating from about 400 BC onwards. The student of Āyurveda was expected to know ten arts that were indispensable in the preparation and application of his medicines: distillation, operative skills, cooking, horticulture, metallurgy, sugar manufacture, pharmacy, analysis and separation of minerals, compounding of metals, and preparation of [[:en:alkalis\|alkalis]].

	The [[Hippocratic Oath\|Hippocratic Oath]] for physicians, attributed to fifth century BC Greece, refers to the existence of "deadly drugs", and [[Medicine in ancient Greece\|ancient Greek physicians]] imported drugs from Egypt and elsewhere. The [[pharmacopoeia\|pharmacopoeia]] ''[[De materia medica\|De materia medica]],'' written between 50 and 70 CE by the Greek physician [[Pedanius Dioscorides\|Pedanius Dioscorides]], was widely read for more than 1,500 years.		The [[Hippocratic Oath\|Hippocratic Oath]] for physicians, attributed to fifth century BC Greece, refers to the existence of "deadly drugs", and [[Medicine in ancient Greece\|ancient Greek physicians]] imported drugs from Egypt and elsewhere. The [[pharmacopoeia\|pharmacopoeia]] ''[[:en:De materia medica\|De materia medica]],'' written between 50 and 70 CE by the Greek physician [[:en:Pedanius Dioscorides\|Pedanius Dioscorides]], was widely read for more than 1,500 years.

	===Medieval pharmacology===		===Medieval pharmacology===